TCIM
CBIO

TIAA CREF Investment Management’s Crescent Biopharma CBIO Stock Holding History

TIAA CREF Investment Management’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$892K Buy
716
+69
+11% +$79K ﹤0.01% 2379
2018
Q4 		$613K Sell
647
-6
-0.9% -$7.22K ﹤0.01% 2482
2018
Q3 		$940K Sell
653
-94
-13% -$142K ﹤0.01% 2447
2018
Q2 		$1.21M Buy
+747
New +$1.28M ﹤0.01% 2416
2017
Q2 		– Sell
-309
Closed -$168K – 3148
2017
Q1 		$168K Sell
309
-4
-1% -$2.46K ﹤0.01% 3014
2016
Q4 		$191K Hold
313
– – ﹤0.01% 3048
2016
Q3 		$224 Sell
313
-15
-5% -$11.5K ﹤0.01% 3039
2016
Q2 		$238K Buy
+328
New +$226K ﹤0.01% 3070
2014
Q2 		– Sell
-323
Closed -$528K – 3135
2014
Q1 		$528K Buy
+323
New +$391K ﹤0.01% 2921

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return